About carfilzomi b
Proteasome inhibitor anticancer medicine
Used for
- Treats multiple myeloma, usually with other medicines.
Usual adult dose
Intravenous infusion, usually 20 mg/m² initially, then 27–56 mg/m² on scheduled treatment days; regimen varies.
Common side effects
- Fatigue, fever, nausea, diarrhea
- Low blood-cell counts and infections
- Shortness of breath
- High blood pressure
Important warnings
- Can cause heart failure, heart attack, or other serious heart problems.
- May cause lung injury, kidney problems, bleeding, or blood clots.
- Treatment requires blood-count, blood-pressure, and organ monitoring.
- Only trained clinicians should prepare and give this medicine.
Pregnancy
May harm an unborn baby. Effective contraception is required during treatment and for a period afterward.
Breastfeeding
Breastfeeding is not recommended during treatment or for at least two weeks after the last dose.
Interactions
- Some antiviral medicines, such as strong CYP3A inhibitors, may increase exposure.
- St. John’s wort may reduce exposure.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.